-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
-
Patient Engagement
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
Advance your patient engagement strategy
Discover new patient engagement possibilities with IQVIA insights, expertise, and technology-driven solutions.
Patient Engagement OverviewPatient Engagement Quick Links
- Commercial Engagement Solutions
- Commercial Patient Engagement Suite
- eCOA
- Clinical Outcome Assessment (COA) instrument library
- Linguistic Validation
- Patient-Centered Endpoints
- Engagement Services (US)
- Association Management
- Recruitment
- Journey Analytics
- Patient Finder
- Disease insights
- Disease Registries
- Treatment satisfaction
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSPresentación
Análisis del mercado farmacéutico con efecto del COVID-19 - Semana 40
Oct 14, 2020
El mercado farmacéutico total se ha ido contrayendo desde finales de abril de forma sostenida.
- Esta semana, pese a presentar un decrecimiento del -1,2% en valores en comparación a 2019, en el acumulado del año el mercado consigue un crecimiento del 0,3%, guiado principalmente por el segmento de medicamentos de prescripción.
- En particular, tanto el mercado de medicamentos como el de Consumer Health, consiguen un balance casi plano en el acumulado del año 2020 frente al del año pasado, con crecimientos en valores del 0,7% y del -0,7% respectivamente. Los decrecimientos que se observan en el acumulado desde la semana 33 o inicio de la segunda oleada frente al acumulado del periodo de transición son similares, lo que indica que el mercado no termina de recuperar.
- La actividad total en la farmacia ha variado mucho desde el inicio de la COVID-19. La actividad en la farmacia ha vuelto a caer ligeramente (-7,1% en número de tickets medio por farmacia semana 40 2020 frente a la misma semana de 2019) y el valor del ticket medio sigue al alza, presentando crecimientos de un 9,9% en comparación a la misma semana del año pasado. Esta dinámica es similar, aunque en menor medida, a los comportamientos que vimos en abril; probablemente debido a las restricciones selectivas con motivo del aumento de incidencia del virus.
- En el mercado de prescripción, mientras que las clases de aparato digestivo y metabólico, sistema nervioso y sistema cardiovascular, presentan crecimientos a YTD, aparato respiratorio y sistema locomotor presentan decrecimientos de -4,7% y del -7,9% respectivamente, como viene siendo habitual en este informe desde el inicio de la desescalada. Concretamente, 4 de las 5 categorías con mayor decrecimiento esta semana están relacionadas con estas dos clases (R y M). Además de estas ATCs, destaca la caída de los antibióticos (-20,6%) y las vacunas (-12,3%).
- La situación para Consumer Health esta semana sigue en línea con lo observado en los últimos meses. Los valores 2020 para CH se sitúan por debajo de los del año pasado de nuevo (-6,3%) impidiendo lograr un crecimiento en el acumulado YTD (-0,7%). A día de hoy, PAC es la única categoría que crece (4,7% YTD 2020 vs. 2019) y PEC se mantiene como la gran perjudicada (-4,0% YTD 2020 vs. 2019). Es importante mencionar que, con el objetivo de comparar las tendencias de los mercados tal y como los conocemos, se han excluido los productos de mascarillas, geles hidroalcohólicos y guantes procedentes de fabricantes que no operan en España.
- Las clases más afectadas por la pandemia tanto en el mercado de prescripción como en el mercado de Consumer Health son las que se relacionan sobre todo con el distanciamiento social y los pocos contagios (por ejemplo, los antiparasitarios de pelo o los anticatarrales / antigripales) o bien por los cambios en el punto de venta, los cuales afectan especialmente a la venta por impulso y a los productos más premium (belleza facial mujer). La preocupación por la situación actual hace que sigan al alza las ventas de mascarillas, termómetros, geles hidroalcohólicos y productos de desinfección de la piel, productos para dormir y de preparados inmunoestimulantes, así como productos con vitamina C.